Cardinal Health Sets Shareholder Meeting Date

Ticker: CAH · Form: 8-K · Filed: Nov 7, 2024 · CIK: 721371

Cardinal Health INC 8-K Filing Summary
FieldDetail
CompanyCardinal Health INC (CAH)
Form Type8-K
Filed DateNov 7, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance

Related Tickers: CAH

TL;DR

Cardinal Health's shareholder meeting is Nov 14th - vote on directors & exec pay.

AI Summary

On November 6, 2024, Cardinal Health, Inc. filed an 8-K report to announce that its annual meeting of shareholders will be held on November 14, 2024. The meeting will include the election of directors and a vote on executive compensation.

Why It Matters

This filing informs shareholders about the upcoming annual meeting where key corporate decisions, including director elections and executive pay, will be voted upon.

Risk Assessment

Risk Level: low — This is a routine filing announcing a shareholder meeting date and agenda items, with no immediate financial or operational risks disclosed.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose is to report the date of Cardinal Health, Inc.'s annual meeting of shareholders, which is November 14, 2024.

When is the annual meeting of Cardinal Health, Inc. shareholders scheduled to take place?

The annual meeting is scheduled for November 14, 2024.

What are the key items to be voted on at the shareholder meeting?

The key items include the election of directors and a vote on executive compensation.

What is the company's principal executive office address?

The principal executive office is located at 7000 Cardinal Place, Dublin, Ohio 43017.

Under which section of the Securities Exchange Act is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 657 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-11-07 16:14:03

Filing Documents

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. Cardinal Health, Inc. (the "Company") held its 2024 Annual Meeting of Shareholders (the "Annual Meeting") on November 6, 2024. See the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on September 16, 2024 and the supplements thereto (the "Proxy Statement") for more information on the four proposals included in the Proxy Statement for the Annual Meeting. Proposal 1 . The shareholders elected the 10 nominees listed below to the Company's Board of Directors, each to serve until the 2025 Annual Meeting of Shareholders and until their successor is duly elected and qualified or until their earlier resignation, removal from office or death, and voted as follows: Nominee For Against Abstained Broker Non-Votes Robert W. Azelby 192,459,502 395,126 365,055 21,165,756 Michelle M. Brennan 191,815,658 1,086,928 317,097 21,165,756 Sheri H. Edison 192,414,107 463,636 341,940 21,165,756 David C. Evans 192,250,048 619,049 350,586 21,165,756 Patricia A. Hemingway Hall 184,775,047 8,127,441 317,195 21,165,756 Jason M. Hollar 191,703,012 1,180,623 336,048 21,165,756 Akhil Johri 192,294,225 578,314 347,144 21,165,756 Gregory B. Kenny 177,414,287 15,477,787 327,609 21,165,756 Nancy Killefer 185,176,038 7,720,227 323,418 21,165,756 Christine A. Mundkur 191,352,587 1,542,731 324,365 21,165,756 Proposal 2 . The shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers ("say-on-pay" vote), and voted as follows: For Against Abstained Broker Non-Votes 172,738,569 19,964,307 516,807 21,165,756 Proposal 3 . The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent auditor for the fiscal year ending June 30, 2025, and voted as follows: For Against Abstained Broker Non-Votes 202,732,608 11,394,141 258,690 0 Proposal 4 . The shareholders did not approve the s

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: November 7, 2024 By: /s/ Jessica L. Mayer Name: Jessica L. Mayer Title: Chief Legal and Compliance Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing